The race for a COVID-19 vaccine
There’s been a flurry of vaccine news since the pandemic began, with a number of drug companies releasing a string of positive early stage results. Anthony Okolie speaks with Tarik Aeta, Healthcare Analyst, TD Asset Management, on the state of COVID-19 vaccine and therapeutics development.